Reflotron desktop analyzer

Manufactured by Roche

Sourced in United Kingdom

The Reflotron Desktop Analyzer is a compact, automated clinical chemistry analyzer designed for in-vitro diagnostic testing. The device performs rapid analysis of a variety of analytes from small sample volumes, enabling quick and efficient results in a clinical setting.

Automatically generated - may contain errors

Lab products found in correlation

Ua 767, by ADInstruments (1 mentions)

Close spelling variants of this product

Reflotron analyzer (4 citations) Reflotron (56 citations)

2 protocols using reflotron desktop analyzer

Anthropometric and Metabolic Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols

All study‐related measurements were performed between 8 and 11 AM following a 12‐hr overnight fast, which included refraining from alcohol or caffeine.
Standard anthropometric measures of height and weight were recorded to determine body mass index (BMI = weight/height²). Systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were measured using an automatic BP monitor (UA‐767; A&D Instruments Ltd, Oxford, UK) to determine mean arterial pressure (MAP = 2/3 DBP + 1/3 SBP). IOP readings were obtained using noncontact tonometry (Pulsair; Keeler Ltd, UK) to determine ocular perfusion pressure (OPP = 2/3 MAP – IOP).
In addition, blood and plasma samples drawn from the antecubital fossa vein were assessed immediately for fasting glucose (GLUC), triglycerides (TG), total cholesterol (CHOL) and high‐density lipoprotein cholesterol (HDL‐c) using the Reflotron Desktop Analyzer (Roche Diagnostics, UK). Low‐density lipoprotein cholesterol (LDL‐c) values were calculated as per the Friedewald equation (Friedewald et al. 1972).

Seshadri S., Ekart A, & Gherghel D. (2015). Ageing effect on flicker‐induced diameter changes in retinal microvessels of healthy individuals. Acta Ophthalmologica, 94(1), e35-e42.

+ Open protocol

+ Expand

Cardiovascular Disease Risk Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols

Blood and plasma samples drawn from the antecubital fossa vein were assessed immediately for fasting glucose (GLUC), triglycerides (TG), total cholesterol (T-CHOL), high-density lipoprotein cholesterol (HDL-C) and glycated haemoglobin (HbA1c) using the Reflotron Desktop Analyzer (Roche Diagnostics, Welwyn Garden City, UK). Low-density lipoprotein cholesterol (LDL-C) values were calculated as per the Friedewald equation [15 (link)].
These variables, in addition to the above parameters, were used to calculate the Framingham Risk Score (FRS) for each individual [16 (link)]. Absolute CVD risk percentage over 10 years was classified as low risk (<10%), intermediate risk (10–20%) and high risk (>20%) [17 (link)].
Additional set of urine samples were also collected and sent to the pathology unit for assessment of albumin/creatinine ratio (ACR).

Seshadri S., Shokr H, & Gherghel D. (2022). Retinal Microvascular Abnormalities and Systemic Arterial Stiffness Are the First Manifestation of Cardiovascular Abnormalities in Patients with Untreated Moderate to Severe Obstructive Sleep Apnoea and with Low to Intermediate Cardiovascular Risk—A Pilot Study. Biomedicines, 10(10), 2669.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!